SELLAS and Merck to begin Phase I/II cancer combination clinical trial

Biopharmaceutical firm SELLAS Life Sciences Group has entered a clinical trial collaboration and supply agreement with Merck to conduct a combination clinical trial targeting multiple cancer types.  
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news